Recombinant human granulocyte-colony-stimulating factor increases the sensitivity of acute myeloid leukemia cells to arsenic trioxide and its possible mechanism 
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3781/j.issn.1000-7431.2019.11.045
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Andi WANG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Hematology, South Campus of Renji Hospital, Shanghai Jiao Tong University School of Medicine
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Acute;
			        		
			        		
			        		
				        		Aquaporin 9;
			        		
			        		
			        		
				        		Arsenic trioxide;
			        		
			        		
			        		
				        		Granulocyte colony-stimulating factor;
			        		
			        		
			        		
				        		Leukemia;
			        		
			        		
			        		
				        		Myeloid
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Tumor
	            		
	            		 2019;39(4):280-291
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	 Objective: To investigate the effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) combined with arsenic trioxide (ATO) (molecular formula: As2O3) on the proliferation and apoptosis of acute myeloid leukemia (AML) cells, and to explore the possible mechanisms. Methods: AML cells HL-60 and THP-1 were pre-treated with rhG-CSF (100 ng/mL), and then treated with different concentrations of As2O3. The relative proliferation rate was detected by CCK-8 method, while the apoptosis and cell cycle distribution were measured by FCM method. The expression levels of aquaporin 9 (AQP9) mRNA and protein in HL-60, THP-1 and acute promyelocytic leukemia NB4 cells as well as HL-60 and THP-1 cells treated with rhG-CSF (100 ng/ mL) were detected by real-time fluorescent quantitative PCR and Western blotting, respectively. Results: RhG-CSF promoted the proliferation of HL-60 and THP-1 cells (both P < 0.01). Compared with the As2O3 group, rhG-CSF pre-treatment combined with 2 μmol/L As2O3 inhibited the proliferation of HL-60 and THP-1 cells (both P < 0.05), rhG-CSF combined with different concentrations of As2O3 increased the apoptotic rates of HL-60 and THP-1 cells (both P < 0.05). As2O3 caused G0/G1 arrest in HL-60 and THP-1 cells (both P < 0.05). rhG-CSF caused S-phase arrest in HL-60 and THP-1 cells (both P < 0.01), the effect was more obvious in rhG-CSF combined with As2O3 group (both P < 0.05). The expressions of AQP9 mRNA and protein in HL-60 and THP-1 cells were lower than those in NB4 cells (all P < 0.01). Compared with the untreated control group, 100 ng/mL rhG-CSF up-regulated the expression levels of AQP9 mRNA and protein in HL-60 and THP-1 cells (all P < 0.05). Conclusion: RhG-CSF can increase the sensitivity of non-M3 AML cells to As2O3, which may be associated with the up-regulation of AQP9 expression.